Cargando…
Plasminogen regulates mesenchymal stem cell–mediated tissue repair after ischemia through Cyr61 activation
Stem cell transplantation has emerged as a promising strategy in regenerative medicine. However, the poor survival and persistence of the transplanted cells, including mesenchymal stem cells (MSCs), in the hostile ischemic microenvironments represents a major therapeutic barrier. Here we report that...
Autores principales: | Duan, Hao, He, Zhenqiang, Lin, Maohuan, Wang, Yanling, Yang, Fan, Mitteer, R. Alan, Kim, Hyun-Jun, Yeo, Eujing, Han, Hongyu, Qin, Ling, Fan, Yi, Gong, Yanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455064/ https://www.ncbi.nlm.nih.gov/pubmed/32759492 http://dx.doi.org/10.1172/jci.insight.131376 |
Ejemplares similares
-
STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018) -
Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019) -
The Roles of CCN1/CYR61 in Pulmonary Diseases
por: Zhu, Yin, et al.
Publicado: (2020) -
Cyr61 Expression is associated with prognosis in patients with colorectal cancer
por: Jeong, Dongjun, et al.
Publicado: (2014) -
Cyr61: a potential therapeutic target for prostate cancer
por: Lin, Chang-Ming, et al.
Publicado: (2014)